Pfizer (PFE) Revenue (2009 - 2026)
Pfizer (PFE) posted quarterly Revenue of $14.5 billion for Q1 2026, up 5.37% year-over-year from $13.7 billion in Q1 2025, and up 140.42% quarter-over-quarter from -$35.8 billion in Q4 2025.
Pfizer (PFE) Revenue (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Revenue for 18 consecutive years, with $14.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 5.37% year-over-year to $14.5 billion; the TTM figure through Mar 2026 stood at -$2.4 billion (down 102.79% YoY), while the FY2025 annual figure was $9.3 billion, up 10.47% from the prior year.
- Revenue grew to $14.5 billion in Q1 2026 per PFE's latest filing, from -$35.8 billion in the prior quarter.
- Across five years, Revenue topped out at $45.9 billion in Q3 2024 and bottomed at -$35.8 billion in Q4 2025.
- Historically, Revenue has averaged $10.7 billion across 5 years, with a median of $12.2 billion in 2024.
- Annual changes were most pronounced in 2023 — Revenue sank 87.42% — and 2024, when it surged 310.23%.
- Pfizer's Revenue stood at $3.3 billion in 2022, then climbed by 5.31% to $3.4 billion in 2023, then surged by 1235.59% to $45.9 billion in 2024, then tumbled by 177.96% to -$35.8 billion in 2025, then jumped by 140.42% to $14.5 billion in 2026.
- Business Quant data shows PFE's Revenue at $14.5 billion in Q1 2026, -$35.8 billion in Q4 2025, and $16.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 13.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 15.03 Bn |
| Mar 29, 2026 | 14.45 Bn |
| Dec 31, 2025 | -35.76 Bn |
| Sep 28, 2025 | 16.65 Bn |
| Jun 29, 2025 | 2.27 Bn |
| Mar 30, 2025 | 13.72 Bn |
| Sep 29, 2024 | 45.86 Bn |
| Jun 30, 2024 | 10.64 Bn |
| Mar 31, 2024 | 14.88 Bn |
| Dec 31, 2023 | 3.43 Bn |
| Jul 2, 2023 | 3.49 Bn |
| Apr 2, 2023 | 3.63 Bn |
| Dec 31, 2022 | 3.26 Bn |
| Jul 3, 2022 | 27.74 Bn |
| Apr 3, 2022 | 25.66 Bn |
| Dec 31, 2021 | 3.42 Bn |
| Oct 3, 2021 | 57.45 Bn |
| Jul 4, 2021 | 18.90 Bn |
| Apr 4, 2021 | 14.52 Bn |
| Sep 27, 2020 | 30.22 Bn |